Tarek Mouhieddine

Dikutip oleh

	Semua	Sejak 2020
Kutipan	3483	2802
indeks-h	29	26
indeks-i10	45	42

760

380

190

570

20142015201620172018201920202021202220232024202536 71 124 115 130 173 271 459 567 640 758 95

Akses publik

Lihat semua

26 artikel

1 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Joshua RichterAssociate Professor, Tisch Cancer Institute: Icahn School of Medicine at Mount SinaiEmail yang diverifikasi di mountsinai.org
Irene GhobrialDana-Farber Cancer InstituteEmail yang diverifikasi di dfci.harvard.edu
Shambavi RichardIcahn School of Medicine at Mount SinaiEmail yang diverifikasi di mountsinai.org
Oliver Van OekelenIcahn School of Medicine at Mount SinaiEmail yang diverifikasi di mountsinai.org
Muhieddine M ItaniPost Doctoral Research Fellow at Massachusetts General HospitalEmail yang diverifikasi di mgh.harvard.edu
Firas KobeissyMorehouse School of MedicineEmail yang diverifikasi di msm.edu
Santiago ThibaudIcahn School of Medicine at Mount SinaiEmail yang diverifikasi di mountsinai.org
Adolfo AlemanIchan School of Medicine at Mount SinaiEmail yang diverifikasi di mssm.edu
Wassim Abou-KheirProfessor- Faculty of Medicine at the American University of BeirutEmail yang diverifikasi di aub.edu.lb
David Todd MelnekoffIcahn School of Medicine at Mt. SinaiEmail yang diverifikasi di columbia.edu
Amin H. NassarYale New Haven Hospital/Yale UniversityEmail yang diverifikasi di yale.edu
Elio AdibHarvard Radiation Oncology ProgramEmail yang diverifikasi di dfci.harvard.edu
Sarah Abou AlaiwiCardiology Fellow, Yale New Haven HospitalEmail yang diverifikasi di yale.edu
Georges DaoudAssistant Professor of Anatomy, Cell Biology and PHysiological Sciences, American University of BeirutEmail yang diverifikasi di aub.edu.lb
Sabrin TahriErasmus Medical Centre, Dana-Farber Cancer InstituteEmail yang diverifikasi di erasmusmc.nl
Romanos Sklavenitis-Pistofidis, MD, P...Dana-Farber Cancer Institute, Broad Institute, Harvard Medical SchoolEmail yang diverifikasi di broadinstitute.org
Darren PanUniversity of California, San FranciscoEmail yang diverifikasi di ucsf.edu
Nagi El SaghirProfessor of Clinical Medicine, American University of BeirutEmail yang diverifikasi di aub.edu.lb
Mark Bustoros, M.D.Weill Cornell Medicine, Cornell UniversityEmail yang diverifikasi di med.cornell.edu
Hisham BahmadDepartment of Pathology and Laboratory Medicine, University of Miami Miller School of MedicineEmail yang diverifikasi di miami.edu

Ikuti

Tarek Mouhieddine

Icahn School of Medicine at Mount Sinai

Email yang diverifikasi di mountsinai.org

Genomics Immunotherapy Multiple myeloma Smoldering myeloma MGUS


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Epidemiology and prognosis of breast cancer in young women HA Assi, KE Khoury, H Dbouk, LE Khalil, TH Mouhieddine, NS El Saghir Journal of thoracic disease 5 (Suppl 1), S2, 2013	536	2013
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020	306	2020
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma O Van Oekelen, CR Gleason, S Agte, K Srivastava, KF Beach, A Aleman, ... Cancer cell 39 (8), 1028-1030, 2021	220	2021
Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression M Bustoros, R Sklavenitis-Pistofidis, J Park, R Redd, B Zhitomirsky, ... Journal of Clinical Oncology 38 (21), 2380-2389, 2020	172	2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward B Wang, O Van Oekelen, TH Mouhieddine, DM Del Valle, J Richter, ... Journal of hematology & oncology 13, 1-12, 2020	150	2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ... Nature communications 11 (1), 2996, 2020	149	2020
Assessing the Lebanese population for their knowledge, attitudes and practices of antibiotic usage TH Mouhieddine, Z Olleik, MM Itani, S Kawtharani, H Nassar, R Hassoun, ... Journal of infection and public health 8 (1), 20-31, 2015	147	2015
Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ... The Journal of clinical investigation 128 (6), 2487-2499, 2018	111	2018
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer WY Chen, SY Liu, YS Chang, JJ Yin, H Yeh, TH Mouhieddine, ... Oncotarget, 2014	109	2014
Monoclonal gammopathy of undetermined significance TH Mouhieddine, LD Weeks, IM Ghobrial Blood, The Journal of the American Society of Hematology 133 (23), 2484-2494, 2019	108	2019
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation AS Nam, N Dusaj, F Izzo, R Murali, RM Myers, TH Mouhieddine, J Sotelo, ... Nature genetics 54 (10), 1514-1526, 2022	91	2022
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors E Adib, AH Nassar, EW Akl, S Abou Alaiwi, PV Nuzzo, TH Mouhieddine, ... Clinical Cancer Research 27 (14), 4025-4035, 2021	86	2021
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors AH Nassar, E Adib, S Abou Alaiwi, T El Zarif, S Groha, EW Akl, PV Nuzzo, ... Cancer Cell 40 (10), 1161-1172. e5, 2022	82	2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy O Van Oekelen, K Nath, TH Mouhieddine, T Farzana, A Aleman, ... Blood 141 (7), 756-765, 2023	78	2023
Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020	68	2020
The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma HF Bahmad, TH Mouhieddine, RM Chalhoub, S Assi, T Araji, F Chamaa, ... Oncotarget 9 (71), 33549, 2018	61	2018
Metformin and ara-a effectively suppress brain cancer by targeting cancer stem/progenitor cells TH Mouhieddine, A Nokkari, MM Itani, F Chamaa, H Bahmad, A Monzer, ... Frontiers in neuroscience 9, 442, 2015	58	2015
Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects TH Mouhieddine, FH Kobeissy, M Itani, A Nokkari, KKW Wang Neural regeneration research 9 (9), 901-906, 2014	58	2014
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis R Boiarsky, NJ Haradhvala, JB Alberge, R Sklavenitis-Pistofidis, ... Nature Communications 13 (1), 7040, 2022	51	2022
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers TH Mouhieddine, H Darwish, L Fawaz, B Yamout, H Tamim, SJ Khoury Clinical Immunology 158 (1), 59-66, 2015	51	2015

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama